IDEAS home Printed from https://ideas.repec.org/a/spr/stabio/v14y2022i1d10.1007_s12561-021-09316-4.html
   My bibliography  Save this article

Sample Size Re-estimation with the Com-Nougue Method to Evaluate Treatment Effect

Author

Listed:
  • Jin Wang

    (Biometrics, Abbott Vascular)

Abstract

The binary endpoint and the time-to-event (TTE) endpoint are the main staple for clinical evaluation. The TTE endpoint is typically utilized when the follow-up is long, and the attrition rate is substantial. In the latter case, if the constant hazard ratio condition is approximately accurate, typically the Cox regression is applied to all available information by accommodating early terminations. However, if the treatment effect is fluctuating over time to such a degree that the proportional hazard ratio assumption is seriously violated, alternative approaches need to be considered, including in the setting of adaptive trial design. Due to the lack of literature focusing on application of the Com-Nougue method in the adaptive trial design, this paper is to highlight the unique features of sample size re-estimation under the Com-Nougue approach in contrast to some typical statistical techniques, with some representative simulations. In most scenarios of the simulations, including both superiority and non-inferiority (NI) tests, constant and piecewise hazard ratio under the exponential distribution, the Com-Nougue method performs well with the adaptive design. Cox regression excels in the proportional hazard ratio setting due to the use of all available data. This paper illustrates the utility of the Com-Nougue method in adaptive clinical trial design. It also provides a simple and convenient approach to calculate the conditional power and sample size under arbitrary underlying true parameter assumptions.

Suggested Citation

  • Jin Wang, 2022. "Sample Size Re-estimation with the Com-Nougue Method to Evaluate Treatment Effect," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 14(1), pages 90-103, April.
    • Handle: RePEc:spr:stabio:v:14:y:2022:i:1:d:10.1007_s12561-021-09316-4
    DOI: 10.1007/s12561-021-09316-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s12561-021-09316-4
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s12561-021-09316-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Lu Chi & H. M. James Hung & Sue-Jane Wang, 1999. "Modification of Sample Size in Group Sequential Clinical Trials," Biometrics, The International Biometric Society, vol. 55(3), pages 853-857, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jingjing Chen, 2019. "A Note of Adaptive Design in Clinical Trials," Biostatistics and Biometrics Open Access Journal, Juniper Publishers Inc., vol. 9(5), pages 107-111, August.
    2. Hanan Hammouri & Mohammed Ali & Marwan Alquran & Areen Alquran & Ruwa Abdel Muhsen & Belal Alomari, 2023. "Adaptive Multiple Testing Procedure for Clinical Trials with Urn Allocation," Mathematics, MDPI, vol. 11(18), pages 1-20, September.
    3. Zhiwei Jiang & Ling Wang & Chanjuan Li & Jielai Xia & Hongxia Jia, 2012. "A Practical Simulation Method to Calculate Sample Size of Group Sequential Trials for Time-to-Event Data under Exponential and Weibull Distribution," PLOS ONE, Public Library of Science, vol. 7(9), pages 1-12, September.
    4. Lingyun Liu & Sam Hsiao & Cyrus R. Mehta, 2018. "Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-assessment," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 10(2), pages 405-419, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:stabio:v:14:y:2022:i:1:d:10.1007_s12561-021-09316-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.